Skip to main content
. 2024 Sep 19;12(9):1075. doi: 10.3390/vaccines12091075

Figure 3.

Figure 3

Summary of MR programmatic problem statements by level of evidence, likelihood of problem occurring, and magnitude of the problem statement.